Suppr超能文献

葡萄糖转运体在肾脏疾病中的分布。

Distribution of glucose transporters in renal diseases.

机构信息

Medical University of Warsaw, Chair & Department of General Biology & Parasitology, Center for Biostructure Research, 5 Chalubinskiego Str., 02-004, Warsaw, Poland.

出版信息

J Biomed Sci. 2017 Aug 31;24(1):64. doi: 10.1186/s12929-017-0371-7.

Abstract

Kidneys play an important role in glucose homeostasis. Renal gluconeogenesis prevents hypoglycemia by releasing glucose into the blood stream. Glucose homeostasis is also due, in part, to reabsorption and excretion of hexose in the kidney.Lipid bilayer of plasma membrane is impermeable for glucose, which is hydrophilic and soluble in water. Therefore, transport of glucose across the plasma membrane depends on carrier proteins expressed in the plasma membrane. In humans, there are three families of glucose transporters: GLUT proteins, sodium-dependent glucose transporters (SGLTs) and SWEET. In kidney, only GLUTs and SGLTs protein are expressed. Mutations within genes that code these proteins lead to different renal disorders and diseases. However, diseases, not only renal, such as diabetes, may damage expression and function of renal glucose transporters.

摘要

肾脏在葡萄糖稳态中起着重要作用。肾脏的糖异生作用通过将葡萄糖释放到血液中防止低血糖。葡萄糖稳态也部分归因于肾脏中己糖的重吸收和排泄。质膜的脂质双层对葡萄糖是不可渗透的,因为葡萄糖是亲水性的,可溶于水。因此,葡萄糖穿过质膜的运输取决于质膜中表达的载体蛋白。在人类中,有三种葡萄糖转运蛋白家族:GLUT 蛋白、钠依赖性葡萄糖转运体(SGLTs)和 SWEET。在肾脏中,仅表达 GLUTs 和 SGLTs 蛋白。编码这些蛋白的基因突变会导致不同的肾脏疾病。然而,不仅是肾脏疾病,如糖尿病,也可能会损害肾脏葡萄糖转运体的表达和功能。

相似文献

1
Distribution of glucose transporters in renal diseases.
J Biomed Sci. 2017 Aug 31;24(1):64. doi: 10.1186/s12929-017-0371-7.
2
Revisiting the physiological roles of SGLTs and GLUTs using positron emission tomography in mice.
J Physiol. 2016 Aug 1;594(15):4425-38. doi: 10.1113/JP271904. Epub 2016 May 10.
3
Human Glucose Transporters in Renal Glucose Homeostasis.
Int J Mol Sci. 2021 Dec 16;22(24):13522. doi: 10.3390/ijms222413522.
4
Glucose transporters in pancreatic islets.
Pflugers Arch. 2020 Sep;472(9):1249-1272. doi: 10.1007/s00424-020-02383-4. Epub 2020 May 12.
5
GLUT, SGLT, and SWEET: Structural and mechanistic investigations of the glucose transporters.
Protein Sci. 2016 Mar;25(3):546-58. doi: 10.1002/pro.2858. Epub 2016 Jan 4.
6
Saving the sweetness: renal glucose handling in health and disease.
Am J Physiol Renal Physiol. 2017 Jul 1;313(1):F55-F61. doi: 10.1152/ajprenal.00046.2017. Epub 2017 Mar 29.
7
Natural Products as Lead Compounds for Sodium Glucose Cotransporter (SGLT) Inhibitors.
Planta Med. 2017 Aug;83(12-13):985-993. doi: 10.1055/s-0043-106050. Epub 2017 Apr 10.
8
Feeding of banana flower and pseudostem to diabetic rats results in modulation of renal GLUTs, TGFβ, PKC and extracellular matrix components.
Nutr Metab Cardiovasc Dis. 2014 Jun;24(6):623-31. doi: 10.1016/j.numecd.2013.12.003. Epub 2013 Dec 25.
9
Glucose transporters in cardiovascular system in health and disease.
Pflugers Arch. 2020 Sep;472(9):1385-1399. doi: 10.1007/s00424-020-02444-8. Epub 2020 Aug 18.

引用本文的文献

1
Human Glucose Transporters in Health and Selected Neurodegenerative Diseases.
Int J Mol Sci. 2025 Jul 31;26(15):7392. doi: 10.3390/ijms26157392.
2
SGLT2i and GLP1-RA exert additive cardiorenal protection with a RAS blocker in uninephrectomized db/db mice.
Front Pharmacol. 2024 Oct 7;15:1415879. doi: 10.3389/fphar.2024.1415879. eCollection 2024.
5
Ageing-Related Alterations in Renal Epithelial Glucose Transport.
Int J Mol Sci. 2023 Nov 17;24(22):16455. doi: 10.3390/ijms242216455.
6
Peroxisome proliferator-activated receptor gamma and its natural agonists in the treatment of kidney diseases.
Front Pharmacol. 2022 Oct 21;13:991059. doi: 10.3389/fphar.2022.991059. eCollection 2022.
7
Molecular mechanisms underlying the role of hypoxia-inducible factor-1 α in metabolic reprogramming in renal fibrosis.
Front Endocrinol (Lausanne). 2022 Jul 25;13:927329. doi: 10.3389/fendo.2022.927329. eCollection 2022.
8
Glucose transporters as markers of diagnosis and prognosis in cancer diseases.
Oncol Rev. 2022 Feb 22;16(1):561. doi: 10.4081/oncol.2022.561.
10
Human Glucose Transporters in Renal Glucose Homeostasis.
Int J Mol Sci. 2021 Dec 16;22(24):13522. doi: 10.3390/ijms222413522.

本文引用的文献

1
Glucose transporters in healthy heart and in cardiac disease.
Int J Cardiol. 2017 Mar 1;230:70-75. doi: 10.1016/j.ijcard.2016.12.083. Epub 2016 Dec 21.
2
Glucose Transporters in Brain: In Health and in Alzheimer's Disease.
J Alzheimers Dis. 2017;55(4):1307-1320. doi: 10.3233/JAD-160841.
3
6
Sodium-glucose linked transporter-2 inhibitors in chronic kidney disease.
ScientificWorldJournal. 2015;2015:317507. doi: 10.1155/2015/317507. Epub 2015 Feb 15.
7
Metabolic effects of SGLT-2 inhibitors beyond increased glucosuria: A review of the clinical evidence.
Diabetes Metab. 2014 Dec;40(6 Suppl 1):S4-S11. doi: 10.1016/S1262-3636(14)72689-8.
8
Beyond Glycosuria: Exploring the intrarenal effects of SGLT₋₂ inhibition in diabetes.
Diabetes Metab. 2014 Dec;40(6 Suppl 1):S17-22. doi: 10.1016/S1262-3636(14)72691-6.
9
Efficacy, safety and regulatory status of SGLT2 inhibitors: focus on canagliflozin.
Nutr Diabetes. 2014 Nov 3;4(11):e143. doi: 10.1038/nutd.2014.40.
10
Inhibition of renal glucose reabsorption as a novel treatment for diabetes patients.
J Bras Nefrol. 2014 Jan-Mar;36(1):80-92. doi: 10.5935/0101-2800.20140014.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验